Screener
Johnson & Johnson JNJ Orthopaedics Restructuring Plan — Restructuring
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Johnson & Johnson’s 10-K, filed February 11, 2026.
- Filed
- Feb 10, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0000200406-26-000016
FAQ
- What is Johnson & Johnson's orthopaedics restructuring plan — restructuring?
- Johnson & Johnson (JNJ) reported orthopaedics restructuring plan — restructuring of $76.75M in Q4 2025.
- What does orthopaedics restructuring plan — restructuring mean?
- This metric represents the specific costs and financial impacts associated with the strategic reorganization and operational streamlining of the orthopaedics business unit. It captures expenses related to workforce adjustments, facility consolidations, and process optimization initiatives designed to improve long-term segment profitability. By isolating these costs, investors can better assess the underlying performance of the core orthopaedics franchise versus one-time transformation expenditures.
Ask your AI about Johnson & Johnson's orthopaedics restructuring plan — restructuring.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude